On Tuesday, Dyne Therapeutics Inc (NASDAQ: DYN) opened lower -7.99% from the last session, before settling in for the closing price of $12.39. Price fluctuations for DYN have ranged from $11.18 to $47.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -5.63% at the time writing. With a float of $84.07 million, this company’s outstanding shares have now reached $102.32 million.
The extent of productivity of a business whose workforce counts for 191 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Dyne Therapeutics Inc (DYN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Dyne Therapeutics Inc is 25.68%, while institutional ownership is 81.00%. The most recent insider transaction that took place on Mar 13 ’25, was worth 1,733. In this transaction Chief Commercial Officer of this company sold 143 shares at a rate of $12.12, taking the stock ownership to the 96,057 shares. Before that another transaction happened on Mar 11 ’25, when Company’s SVP, Head of Finance & Admin. sold 1,343 for $11.38, making the entire transaction worth $15,283. This insider now owns 122,330 shares in total.
Dyne Therapeutics Inc (DYN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.85 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -5.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.20% during the next five years compared to -59.45% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Check out the current performance indicators for Dyne Therapeutics Inc (DYN). In the past quarter, the stock posted a quick ratio of 15.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.35, a number that is poised to hit -0.85 in the next quarter and is forecasted to reach -3.69 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
The latest stats from [Dyne Therapeutics Inc, DYN] show that its last 5-days average volume of 2.19 million was superior to 2.16 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 40.05%. Additionally, its Average True Range was 0.80.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 0.90%, which indicates a significant decrease from 13.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.63% in the past 14 days, which was lower than the 86.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.52, while its 200-day Moving Average is $28.93. Now, the first resistance to watch is $12.09. This is followed by the second major resistance level at $12.78. The third major resistance level sits at $13.15. If the price goes on to break the first support level at $11.04, it is likely to go to the next support level at $10.67. The third support level lies at $9.98 if the price breaches the second support level.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
There are currently 113,121K shares outstanding in the company with a market cap of 1.29 billion. Presently, the company’s annual sales total 0 K according to its annual income of -317,420 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -89,540 K.
